Skip to content
value.today

Pivot Medical Inc.

Total raised
$43 M
4 rounds on record
Latest round
$32 M
Oct 2011
First round on record
Aug 2009
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Pivot Medical Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Oct 2011$32 MNo. 4$10 to $50 million

Pivot Medical Inc.: Raise no. 4, Oct 2011

Investors in this round

10 investors had bought by the notice of Nov 7, 2011: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$32 M of $32 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • James S. Flom · Executive Officer
  • John Giroux · Executive Officer, Director
  • Julian L. Nikolchev · Executive Officer, Director
  • Matthew L. Frushell · Executive Officer
  • Guy L. Mayer · Director
  • John F. Maroney · Director
  • John L. Savarese · Director
  • Michael S. Lynn · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Funds to be used for working capital.”

Signed by John Giroux, President, CEO. Source: SEC Form D, newest notice filed Nov 7, 2011. Read the notice at the SEC.

equitySEC
Jun 2011$2 MNo. 3$2 to $10 million

Pivot Medical Inc.: Raise no. 3, Jun 2011

Investors in this round

2 investors had bought by the notice of Jul 11, 2011: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $5 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • John Giroux · Executive Officer, Director
  • Julian L. Nikolchev · Executive Officer, Director
  • Matthew L. Frushell · Executive Officer
  • Guy L. Mayer · Director
  • John L. Savarese · Director
  • Robert L. More · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Funds to be used for working capital”

Signed by John Giroux, President, CEO. Source: SEC Form D, newest notice filed Jul 11, 2011. Read the notice at the SEC.

debt, optionsSEC
Dec 2010$3 MNo. 2$2 to $10 million

Pivot Medical Inc.: Raise no. 2, Dec 2010

Investors in this round

2 investors had bought by the notice of Dec 21, 2010: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $5 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • John Giroux · Executive Officer, Director
  • Julian L. Nikolchev · Executive Officer, Director
  • Matthew L. Frushell · Executive Officer
  • Guy L. Mayer · Director
  • John L. Savarese · Director
  • Robert L. More · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Ann Coppel, Sr. Legal Assistant. Source: SEC Form D, newest notice filed Dec 21, 2010. Read the notice at the SEC.

debt, optionsSEC
Aug 2009$6 MNo. 1$2 to $10 million

Pivot Medical Inc.: Raise no. 1, Aug 2009

Investors in this round

3 investors had bought by the notice of Aug 24, 2009: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $10 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Julian Nikolchev · Executive Officer, Director
  • Matthew Frushell · Executive Officer
  • John Savarese · Director
  • Trevor Moody · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Funds to be used for working capital.”

Signed by Ann Coppel, Sr. Legal Assistant. Source: SEC Form D, newest notice filed Aug 24, 2009. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Pivot Medical Inc. chose not to state its revenue in its newest notice of a funding round (Nov 2011).

    SEC Form D · Nov 2011

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Nov 2011

That is all the official record says: Pivot Medical Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Pivot Medical Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 10 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Pivot Medical Inc.
NameRoleNamed in
James S. FlomExecutive officerNov 2011
John GirouxExecutive officerNov 2011
Julian L. NikolchevExecutive officerNov 2011
Matthew L. FrushellExecutive officerNov 2011
Julian NikolchevExecutive officerAug 2009
Matthew FrushellExecutive officerAug 2009
Guy L. MayerDirectorNov 2011
John F. MaroneyDirectorNov 2011
John GirouxDirectorNov 2011
John L. SavareseDirectorNov 2011
Julian L. NikolchevDirectorNov 2011
Michael S. LynnDirectorNov 2011
Robert L. MoreDirectorJul 2011
John SavareseDirectorAug 2009
Julian NikolchevDirectorAug 2009
Trevor MoodyDirectorAug 2009